首页 > 最新文献

Yonago acta medica最新文献

英文 中文
Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer. 可切除或边缘性可切除胰腺癌围手术期治疗的当前价值。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.014
Yuki Murakami, Teruhisa Sakamoto, Takehiko Hanaki, Naruo Tokuyasu, Yoshiyuki Fujiwara

Invasive pancreatic ductal carcinoma is a representative refractory malignant tumor, and even with the development of early diagnosis and treatment techniques, the treatment outcome has been remarkably poor. Surgical resection is the curative treatment for resectable pancreatic cancer and borderline resectable pancreatic cancer. However, the survival rate in patients with pancreatic cancer treated by resection alone is low because of the high postoperative recurrence rate. In this review article, we report recent studies on perioperative treatment for pancreatic cancer. Perioperative therapy is the addition of chemotherapy or radiation therapy before or after surgery to improve resectability and curative effects. Because it is difficult to cure redsecttable pancreatic cancer by surgery alone, multidisciplinary treatment combined with perioperative adjuvant chemotherapy is the current standard of care. Although perioperative chemotherapy and chemoradiotherapy have been investigated for borderline resectable pancreatic cancer, the effectiveness of preoperative treatment has not been sufficiently proven. Potentially curative pancreatic cancer is treated by surgery plus perioperative therapy; treatment cannot be either alone. We regard the successful completion of surgery and perioperative care as the key to improving treatment outcomes. Therefore, ongoing randomized controlled trials for the treatment of BR-pancreatic cancer are expected to induce further improvements survival outcomes of patients with BR-pancreatic cancer.

浸润性胰腺导管癌是一种典型的难治性恶性肿瘤,即使早期诊断和治疗技术的发展,其治疗效果也非常差。手术切除是可切除胰腺癌和交界性可切除胰腺癌的根治性治疗方法。然而,单纯切除胰腺癌患者的生存率较低,因为术后复发率高。在这篇综述文章中,我们报告了胰腺癌围手术期治疗的最新研究。围手术期治疗是指术前或术后增加化疗或放疗以提高可切除性和疗效。由于单纯手术治疗难以治愈可切除的胰腺癌,多学科联合围手术期辅助化疗是目前的治疗标准。虽然围手术期化疗和放化疗已被研究用于边缘性可切除胰腺癌,但术前治疗的有效性尚未得到充分证实。可能治愈的胰腺癌通过手术加围手术期治疗;治疗不能单独进行。我们认为手术的顺利完成和围手术期护理是提高治疗效果的关键。因此,正在进行的br -胰腺癌治疗的随机对照试验有望进一步改善br -胰腺癌患者的生存结果。
{"title":"Current Value of Perioperative Therapies for Resectable or Borderline Resectable Pancreatic Cancer.","authors":"Yuki Murakami,&nbsp;Teruhisa Sakamoto,&nbsp;Takehiko Hanaki,&nbsp;Naruo Tokuyasu,&nbsp;Yoshiyuki Fujiwara","doi":"10.33160/yam.2023.05.014","DOIUrl":"https://doi.org/10.33160/yam.2023.05.014","url":null,"abstract":"<p><p>Invasive pancreatic ductal carcinoma is a representative refractory malignant tumor, and even with the development of early diagnosis and treatment techniques, the treatment outcome has been remarkably poor. Surgical resection is the curative treatment for resectable pancreatic cancer and borderline resectable pancreatic cancer. However, the survival rate in patients with pancreatic cancer treated by resection alone is low because of the high postoperative recurrence rate. In this review article, we report recent studies on perioperative treatment for pancreatic cancer. Perioperative therapy is the addition of chemotherapy or radiation therapy before or after surgery to improve resectability and curative effects. Because it is difficult to cure redsecttable pancreatic cancer by surgery alone, multidisciplinary treatment combined with perioperative adjuvant chemotherapy is the current standard of care. Although perioperative chemotherapy and chemoradiotherapy have been investigated for borderline resectable pancreatic cancer, the effectiveness of preoperative treatment has not been sufficiently proven. Potentially curative pancreatic cancer is treated by surgery plus perioperative therapy; treatment cannot be either alone. We regard the successful completion of surgery and perioperative care as the key to improving treatment outcomes. Therefore, ongoing randomized controlled trials for the treatment of BR-pancreatic cancer are expected to induce further improvements survival outcomes of patients with BR-pancreatic cancer.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"202-207"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203636/pdf/yam-66-202.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconstruction for Bilateral Internal Jugular Vein Perfusion Disruption. 双侧颈内静脉灌注中断的重建。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.019
Ryunosuke Umeda, Yoshiko Suyama, Kohei Fukuoka, Maki Morita, Kento Ikuta, Haruka Kanayama, Makoto Ohga, Makoto Nakagaki, Takahiro Fukuhara, Kazunori Fujiwara, Shunjiro Yagi

When resecting the internal jugular veins bilaterally in surgery for head and neck cancer, it is necessary to perform neck dissection in two stages or to reconstruct the internal jugular veins in one stage. Reconstruction of the internal jugular vein using grafting or direct anastomosis to the external jugular vein have both been reported. We report the case of a 53-year-old man with accidental injury to the left internal jugular vein after resection of the right internal jugular vein for supraglottic cancer. The left internal jugular vein was damaged near the inflow of the subclavian vein, making vein grafting difficult. Therefore, internal jugular venous return was reestablished by end-to-side anastomosis of the left internal jugular vein to the left external jugular vein system. In this surgical procedure, by incising the internal jugular vein obliquely, it was not necessary to match the calibers of the internal jugular vein and the external jugular vein system, and a smooth hemodynamic body was reconstructed. In addition, we were able to reconstruct the internal jugular vein while preserving blood flow in the external jugular vein system. End-to-side anastomosis of the internal jugular vein to the external jugular system is an option for internal jugular vein reconstruction.

头颈癌手术切除双侧颈内静脉时,需要分两期进行颈部清扫或一期重建颈内静脉。颈内静脉移植或直接与颈外静脉吻合重建均有报道。我们报告一个53岁的男子意外伤害左颈内静脉后,切除右颈内静脉为声门上癌。左侧颈内静脉在锁骨下静脉流入处受损,静脉移植困难。因此,通过左颈内静脉与左颈外静脉系统端侧吻合重建颈内静脉回流。本手术通过斜切颈内静脉,无需与颈内静脉和颈外静脉系统口径匹配,重建了光滑的血流动力学体。此外,我们能够重建颈内静脉,同时保持颈外静脉系统的血液流动。颈内静脉与颈外静脉系统端侧吻合是颈内静脉重建的一种选择。
{"title":"Reconstruction for Bilateral Internal Jugular Vein Perfusion Disruption.","authors":"Ryunosuke Umeda,&nbsp;Yoshiko Suyama,&nbsp;Kohei Fukuoka,&nbsp;Maki Morita,&nbsp;Kento Ikuta,&nbsp;Haruka Kanayama,&nbsp;Makoto Ohga,&nbsp;Makoto Nakagaki,&nbsp;Takahiro Fukuhara,&nbsp;Kazunori Fujiwara,&nbsp;Shunjiro Yagi","doi":"10.33160/yam.2023.05.019","DOIUrl":"https://doi.org/10.33160/yam.2023.05.019","url":null,"abstract":"<p><p>When resecting the internal jugular veins bilaterally in surgery for head and neck cancer, it is necessary to perform neck dissection in two stages or to reconstruct the internal jugular veins in one stage. Reconstruction of the internal jugular vein using grafting or direct anastomosis to the external jugular vein have both been reported. We report the case of a 53-year-old man with accidental injury to the left internal jugular vein after resection of the right internal jugular vein for supraglottic cancer. The left internal jugular vein was damaged near the inflow of the subclavian vein, making vein grafting difficult. Therefore, internal jugular venous return was reestablished by end-to-side anastomosis of the left internal jugular vein to the left external jugular vein system. In this surgical procedure, by incising the internal jugular vein obliquely, it was not necessary to match the calibers of the internal jugular vein and the external jugular vein system, and a smooth hemodynamic body was reconstructed. In addition, we were able to reconstruct the internal jugular vein while preserving blood flow in the external jugular vein system. End-to-side anastomosis of the internal jugular vein to the external jugular system is an option for internal jugular vein reconstruction.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"317-321"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203646/pdf/yam-66-317.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9527078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the Hemoglobin Concentration in Drainage Fluid After Surgery by Absorbance Spectrophotometry Using an Optical Sensor. 光学传感器吸收分光光度法评价术后引流液中血红蛋白浓度。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.020
Wataru Miyauchi, Masashi Fujii, Naofumi Saiki, Masaru Ueki, Shohei Sawata, Masahiro Makinoya, Yoshiyuki Fujiwara

Background: A drain is often placed in the abdominal cavity for postoperative monitoring and early detection of complications such as rebleeding and pancreatic or bile leaks. Since determining the color of the drainage fluid is subjective, an objective method of judging color is needed.

Methods: The hemoglobin concentration of the drainage fluid after gastrointestinal surgery was measured using the Hemato Check Module, a newly developed instrument capable of absorbance analysis with an optical sensor. The correlation between the results and those measured by an existing blood count measuring device (XN3000) was investigated.

Results: A total of 215 specimens were analyzed in 43 patients. For the correlation analysis, there was a strong positive correlation with a correlation coefficient of 0.884 (P < 0.001). The Hemato Check Module showed a clear proportional error compared to the XN3000.

Conclusion: The Hemato Check Module was a convenient and accurate instrument for measuring hemoglobin concentration in waste fluid to determine the presence of blood.

背景:通常在腹腔内放置引流管,用于术后监测和早期发现并发症,如再出血和胰腺或胆汁泄漏。由于确定引流液的颜色是主观的,因此需要一种客观的判断颜色的方法。方法:采用新开发的光学传感器吸光度分析仪器Hemato Check Module检测胃肠道术后引流液血红蛋白浓度。研究结果与现有血球计数测量仪(XN3000)测量结果的相关性。结果:43例患者共分析标本215份。相关性分析显示,两者呈正相关,相关系数为0.884 (P < 0.001)。与XN3000相比,Hemato Check Module显示出明显的比例误差。结论:血色素检测模块是一种简便、准确的废液血红蛋白浓度检测仪器。
{"title":"Evaluation of the Hemoglobin Concentration in Drainage Fluid After Surgery by Absorbance Spectrophotometry Using an Optical Sensor.","authors":"Wataru Miyauchi,&nbsp;Masashi Fujii,&nbsp;Naofumi Saiki,&nbsp;Masaru Ueki,&nbsp;Shohei Sawata,&nbsp;Masahiro Makinoya,&nbsp;Yoshiyuki Fujiwara","doi":"10.33160/yam.2023.05.020","DOIUrl":"https://doi.org/10.33160/yam.2023.05.020","url":null,"abstract":"<p><strong>Background: </strong>A drain is often placed in the abdominal cavity for postoperative monitoring and early detection of complications such as rebleeding and pancreatic or bile leaks. Since determining the color of the drainage fluid is subjective, an objective method of judging color is needed.</p><p><strong>Methods: </strong>The hemoglobin concentration of the drainage fluid after gastrointestinal surgery was measured using the Hemato Check Module, a newly developed instrument capable of absorbance analysis with an optical sensor. The correlation between the results and those measured by an existing blood count measuring device (XN3000) was investigated.</p><p><strong>Results: </strong>A total of 215 specimens were analyzed in 43 patients. For the correlation analysis, there was a strong positive correlation with a correlation coefficient of 0.884 (<i>P</i> < 0.001). The Hemato Check Module showed a clear proportional error compared to the XN3000.</p><p><strong>Conclusion: </strong>The Hemato Check Module was a convenient and accurate instrument for measuring hemoglobin concentration in waste fluid to determine the presence of blood.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"281-286"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203633/pdf/yam-66-281.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9527080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical Anti-Glomerular Basement Membrane Nephritis After the First Dose of the Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine. 非典型抗肾小球基底膜肾炎第一次剂量后冠状病毒2mrna疫苗。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.008
Shotaro Hoi, Masaya Ogawa, Chishio Munemura, Tomoaki Takata, Hajime Isomoto

Atypical anti-glomerular basement membrane (GBM) nephritis is a slowly progressive characterized by linear deposition of immunoglobulin (Ig) G in the GBM without circulating anti-GBM antibodies or lung involvement. There is no established therapy for this disease, and efficacy of the immunosuppressive treatment is questionable. A few cases of atypical anti-GBM nephritis have been reported after administration of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. Classic anti-GBM disease has also been reported after the administration of the second dose of the SARS-CoV-2 vaccine. Herein, we present the case of a SARS-CoV-2 vaccine-induced atypical anti-GBM nephritis that developed after the first dose and was unresponsive to immunosuppressive therapy. A 57-year-old Japanese woman developed edema 11 days after the first dose of the SARS-CoV-2 mRNA vaccine. She developed nephrotic-range proteinuria and microscopic hematuria. Renal biopsy revealed endocapillary proliferative glomerulonephritis with linear IgG deposition. However, electron-dense deposits were not detected on electron microscopy. The patient tested negative for circulating anti-GBM antibodies and was diagnosed with atypical anti-GBM nephritis. Although steroids and mizoribine were administered, the patient's renal function deteriorated. In conclusion, atypical anti-GBM nephritis may have earlier onset than the classic anti-GBM disease. Given its uncertainty of effectiveness, immunosuppressive agents should be carefully used for SARS-CoV-2 mRNA vaccine-induced atypical anti-GBM nephritis.

非典型抗肾小球基底膜肾炎(GBM)是一种缓慢进展的肾炎,其特征是免疫球蛋白(Ig) G在GBM内呈线性沉积,无循环抗GBM抗体或肺部受累。目前尚无针对这种疾病的既定治疗方法,免疫抑制治疗的疗效值得怀疑。在接种严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) mRNA疫苗后,报告了少数非典型抗gbm肾炎病例。在注射第二剂SARS-CoV-2疫苗后,也报告了典型的抗gbm疾病。在此,我们报告了一例SARS-CoV-2疫苗诱导的非典型抗gbm肾炎,该肾炎在首次接种后发生,对免疫抑制治疗无反应。一名57岁的日本妇女在接种第一剂SARS-CoV-2 mRNA疫苗11天后出现水肿。她出现肾性蛋白尿和显微镜下血尿。肾活检显示毛细血管内增生性肾小球肾炎伴线状IgG沉积。然而,在电子显微镜下没有检测到电子致密沉积物。患者循环抗gbm抗体检测呈阴性,诊断为非典型抗gbm肾炎。尽管使用了类固醇和米佐利滨,患者的肾功能还是恶化了。总之,非典型抗gbm肾炎可能比典型抗gbm肾炎发病早。鉴于其有效性的不确定性,对于SARS-CoV-2 mRNA疫苗诱导的非典型抗gbm肾炎,应谨慎使用免疫抑制剂。
{"title":"Atypical Anti-Glomerular Basement Membrane Nephritis After the First Dose of the Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine.","authors":"Shotaro Hoi,&nbsp;Masaya Ogawa,&nbsp;Chishio Munemura,&nbsp;Tomoaki Takata,&nbsp;Hajime Isomoto","doi":"10.33160/yam.2023.05.008","DOIUrl":"https://doi.org/10.33160/yam.2023.05.008","url":null,"abstract":"<p><p>Atypical anti-glomerular basement membrane (GBM) nephritis is a slowly progressive characterized by linear deposition of immunoglobulin (Ig) G in the GBM without circulating anti-GBM antibodies or lung involvement. There is no established therapy for this disease, and efficacy of the immunosuppressive treatment is questionable. A few cases of atypical anti-GBM nephritis have been reported after administration of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. Classic anti-GBM disease has also been reported after the administration of the second dose of the SARS-CoV-2 vaccine. Herein, we present the case of a SARS-CoV-2 vaccine-induced atypical anti-GBM nephritis that developed after the first dose and was unresponsive to immunosuppressive therapy. A 57-year-old Japanese woman developed edema 11 days after the first dose of the SARS-CoV-2 mRNA vaccine. She developed nephrotic-range proteinuria and microscopic hematuria. Renal biopsy revealed endocapillary proliferative glomerulonephritis with linear IgG deposition. However, electron-dense deposits were not detected on electron microscopy. The patient tested negative for circulating anti-GBM antibodies and was diagnosed with atypical anti-GBM nephritis. Although steroids and mizoribine were administered, the patient's renal function deteriorated. In conclusion, atypical anti-GBM nephritis may have earlier onset than the classic anti-GBM disease. Given its uncertainty of effectiveness, immunosuppressive agents should be carefully used for SARS-CoV-2 mRNA vaccine-induced atypical anti-GBM nephritis.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"300-305"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203639/pdf/yam-66-300.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Aggressive Aneurysm Sac Embolization Before Endovascular Abdominal Aneurysm Repair in Preventing Type II Endoleak and Sac Expansion. 血管内动脉瘤修复前侵袭性动脉瘤囊栓塞在预防II型动脉瘤内漏和囊扩张中的作用。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.010
Yasushi Yoshikawa, Satoru Kishimoto, Shohei Takasugi, Yuichiro Kishimoto, Takeshi Onohara, Kunitaka Kumagai, Rikuto Nii, Nozomi Kishimoto, Yuki Yoshikawa, Shinsaku Yata, Shinya Fujii, Motonobu Nishimura

Background: This study aimed to evaluate the effect of aggressive embolization of side branches arising from the aneurysmal sac before endovascular aneurysm repair.

Methods: This retrospective study included 95 patients who underwent endovascular infrarenal abdominal aortic aneurysm repair at Tottori University Hospital between October 2016 and January 2021. Of these, 54 underwent standard endovascular aneurysm repair (conventional group), and 41 underwent coiling of the inferior mesenteric and lumbar arteries before undergoing endovascular aneurysm repair (embolization group). The occurrence of type II endoleak, change in aneurysmal sac diameter, and reintervention rate due to type II endoleak during follow-up were evaluated.

Results: Compared to the conventional group, the embolization group had a significantly lower incidence of type II endoleak, more frequent aneurysmal sac shrinkage, and lower aneurysmal sac growth related to type II endoleak.

Conclusion: Our results demonstrated the effectiveness of aggressive aneurysmal sac embolization before endovascular aneurysm repair to prevent type II endoleak and the consequent long-term aneurysmal sac enlargement.

背景:本研究旨在评价血管内动脉瘤修复前对动脉瘤囊侧支进行积极栓塞的效果。方法:本回顾性研究纳入了2016年10月至2021年1月期间在鸟取大学医院接受血管内肾下腹主动脉瘤修复术的95例患者。其中,54例接受了标准的血管内动脉瘤修复术(常规组),41例在进行血管内动脉瘤修复术前对肠系膜下动脉和腰椎动脉进行了卷取(栓塞组)。随访期间观察II型内漏的发生情况、动脉瘤囊直径的变化及II型内漏的再干预率。结果:与常规组相比,栓塞组II型内漏发生率明显降低,动脉瘤囊收缩频率更高,与II型内漏相关的动脉瘤囊生长更低。结论:我们的研究结果表明,在血管内动脉瘤修复前进行积极的动脉瘤囊栓塞可以预防II型动脉瘤内漏和由此引起的长期动脉瘤囊扩大。
{"title":"Role of Aggressive Aneurysm Sac Embolization Before Endovascular Abdominal Aneurysm Repair in Preventing Type II Endoleak and Sac Expansion.","authors":"Yasushi Yoshikawa,&nbsp;Satoru Kishimoto,&nbsp;Shohei Takasugi,&nbsp;Yuichiro Kishimoto,&nbsp;Takeshi Onohara,&nbsp;Kunitaka Kumagai,&nbsp;Rikuto Nii,&nbsp;Nozomi Kishimoto,&nbsp;Yuki Yoshikawa,&nbsp;Shinsaku Yata,&nbsp;Shinya Fujii,&nbsp;Motonobu Nishimura","doi":"10.33160/yam.2023.05.010","DOIUrl":"https://doi.org/10.33160/yam.2023.05.010","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the effect of aggressive embolization of side branches arising from the aneurysmal sac before endovascular aneurysm repair.</p><p><strong>Methods: </strong>This retrospective study included 95 patients who underwent endovascular infrarenal abdominal aortic aneurysm repair at Tottori University Hospital between October 2016 and January 2021. Of these, 54 underwent standard endovascular aneurysm repair (conventional group), and 41 underwent coiling of the inferior mesenteric and lumbar arteries before undergoing endovascular aneurysm repair (embolization group). The occurrence of type II endoleak, change in aneurysmal sac diameter, and reintervention rate due to type II endoleak during follow-up were evaluated.</p><p><strong>Results: </strong>Compared to the conventional group, the embolization group had a significantly lower incidence of type II endoleak, more frequent aneurysmal sac shrinkage, and lower aneurysmal sac growth related to type II endoleak.</p><p><strong>Conclusion: </strong>Our results demonstrated the effectiveness of aggressive aneurysmal sac embolization before endovascular aneurysm repair to prevent type II endoleak and the consequent long-term aneurysmal sac enlargement.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"232-238"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203641/pdf/yam-66-232.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Trimming Technique: A Case Report of a Novel Surgical Approach for Cesarean Scar Dehiscence During Cesarean Section. 切边技术:一种治疗剖宫产术中瘢痕裂开的新手术方法。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.004
Daisuke Katsura, Shunichiro Tsuji, Takako Hoshiyama, Rika Zen, Ayako Inatomi, Takashi Murakami

Cesarean section can lead to residual myometrial thickness thinning and cesarean scar syndrome. We report a novel trimming technique for residual myometrial thickness recovery in women with cesarean scar syndrome. Case 1: A 33-year-old woman who developed cesarean scar syndrome (CSS) and abnormal uterine bleeding post-cesarean scar became pregnant following hysteroscopic treatment. The myometrium at previous scar was dehiscent; therefore, a transverse incision was made above the scar. Post-operative uterine recovery failed owing to lochia retention, and developed cesarean scar syndrome again. Case 2: A 29-year-old woman who developed cesarean scar syndrome post-cesarean section became pregnant spontaneously. The myometrium at the previous scar was dehiscent like case 1. Scar repair was performed using a trimming technique during cesarean section; there were no subsequent complications and she conceived again spontaneously. Performing this novel surgical procedure during cesarean section may contribute to residual myometrial thickness recovery in women with cesarean scar syndrome.

剖宫产可导致残余肌层厚度变薄和剖宫产疤痕综合征。我们报告了一种新的修剪技术,用于女性剖宫产疤痕综合征的残余肌层厚度恢复。病例1:33岁女性剖宫产瘢痕综合征(CSS)及剖宫产瘢痕后子宫异常出血,经宫腔镜治疗后成功怀孕。既往瘢痕处肌层开裂;因此,在疤痕上方做一个横向切口。术后因恶露潴留导致子宫恢复失败,再次发生剖宫产瘢痕综合征。病例2:一名29岁女性,剖宫产术后出现剖宫产疤痕综合征,自然怀孕。既往瘢痕处肌层开裂,与病例1相似。剖宫产术中瘢痕修复采用切边技术;没有后续并发症,她再次自然受孕。在剖宫产术中进行这种新颖的外科手术可能有助于剖宫产疤痕综合征妇女残余肌层厚度的恢复。
{"title":"A Trimming Technique: A Case Report of a Novel Surgical Approach for Cesarean Scar Dehiscence During Cesarean Section.","authors":"Daisuke Katsura,&nbsp;Shunichiro Tsuji,&nbsp;Takako Hoshiyama,&nbsp;Rika Zen,&nbsp;Ayako Inatomi,&nbsp;Takashi Murakami","doi":"10.33160/yam.2023.05.004","DOIUrl":"https://doi.org/10.33160/yam.2023.05.004","url":null,"abstract":"<p><p>Cesarean section can lead to residual myometrial thickness thinning and cesarean scar syndrome. We report a novel trimming technique for residual myometrial thickness recovery in women with cesarean scar syndrome. Case 1: A 33-year-old woman who developed cesarean scar syndrome (CSS) and abnormal uterine bleeding post-cesarean scar became pregnant following hysteroscopic treatment. The myometrium at previous scar was dehiscent; therefore, a transverse incision was made above the scar. Post-operative uterine recovery failed owing to lochia retention, and developed cesarean scar syndrome again. Case 2: A 29-year-old woman who developed cesarean scar syndrome post-cesarean section became pregnant spontaneously. The myometrium at the previous scar was dehiscent like case 1. Scar repair was performed using a trimming technique during cesarean section; there were no subsequent complications and she conceived again spontaneously. Performing this novel surgical procedure during cesarean section may contribute to residual myometrial thickness recovery in women with cesarean scar syndrome.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"287-291"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203637/pdf/yam-66-287.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Construction of an Automatic Quantification Method for Bone Marrow Cellularity Using Image Analysis Software. 利用图像分析软件构建骨髓细胞含量自动定量方法。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.011
Yuki Hatayama, Yukari Endo, Nao Kojima, Noriko Yamashita, Takuya Iwamoto, Hiroya Namba, Hitomi Ichikawa, Koji Kawamura, Tetsuya Fukuda, Toru Motokura

Although rapid, the evaluation of bone marrow (BM) cellularity is semi-quantitative and largely dependent upon visual estimates. We aimed to construct an automatic quantification method using image analysis software. We used hematoxylin and eosin (HE)-stained specimens of BM biopsies and clots from patients who underwent BM examination at Tottori University Hospital from 2020 to 2022. We compared image analysis (Methods A, B, and C) with visual estimates in pathology reports of 91 HE specimens in 54 cases (29 males, 25 females), including 38 biopsy and 53 clot specimens. Cellularity was visually scored as hypocellular (n = 17), normocellular (n = 44), or hypercellular (n = 30). Compared with the visual estimates, intraclass correlation coefficients for Methods A, B, and C were 0.80, 0.85, and 0.88, respectively. The most appropriate values were obtained with Method C which detected both non-fatty and cell nuclear areas.

虽然快速,骨髓(BM)细胞的评价是半定量的,很大程度上依赖于视觉估计。目的是利用图像分析软件构建一种自动定量方法。我们使用了2020年至2022年在鸟取县大学医院接受BM检查的患者的BM活检和凝块的苏木精和伊红(HE)染色标本。我们将54例(男性29例,女性25例)91例HE标本的病理报告中的图像分析(方法A、B和C)与视觉估计进行了比较,其中包括38例活检标本和53例凝块标本。细胞数量目测分为低细胞(n = 17)、正常细胞(n = 44)和高细胞(n = 30)。与目测值相比,方法A、B和C的类内相关系数分别为0.80、0.85和0.88。方法C在检测非脂肪区和细胞核区时得到最合适的值。
{"title":"Construction of an Automatic Quantification Method for Bone Marrow Cellularity Using Image Analysis Software.","authors":"Yuki Hatayama,&nbsp;Yukari Endo,&nbsp;Nao Kojima,&nbsp;Noriko Yamashita,&nbsp;Takuya Iwamoto,&nbsp;Hiroya Namba,&nbsp;Hitomi Ichikawa,&nbsp;Koji Kawamura,&nbsp;Tetsuya Fukuda,&nbsp;Toru Motokura","doi":"10.33160/yam.2023.05.011","DOIUrl":"https://doi.org/10.33160/yam.2023.05.011","url":null,"abstract":"<p><p>Although rapid, the evaluation of bone marrow (BM) cellularity is semi-quantitative and largely dependent upon visual estimates. We aimed to construct an automatic quantification method using image analysis software. We used hematoxylin and eosin (HE)-stained specimens of BM biopsies and clots from patients who underwent BM examination at Tottori University Hospital from 2020 to 2022. We compared image analysis (Methods A, B, and C) with visual estimates in pathology reports of 91 HE specimens in 54 cases (29 males, 25 females), including 38 biopsy and 53 clot specimens. Cellularity was visually scored as hypocellular (<i>n</i> = 17), normocellular (<i>n</i> = 44), or hypercellular (<i>n</i> = 30). Compared with the visual estimates, intraclass correlation coefficients for Methods A, B, and C were 0.80, 0.85, and 0.88, respectively. The most appropriate values were obtained with Method C which detected both non-fatty and cell nuclear areas.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"322-325"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203644/pdf/yam-66-322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapid Multiplex RT-PCR for Influenza A and B by Genesoc®, a Microfluidic PCR System. Genesoc®微流控PCR系统对甲型和乙型流感病毒的快速多重RT-PCR检测。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.007
Miyako Takata, Masaki Nakamoto, Tsuyoshi Kitaura, Kensaku Okada, Akeno Tsuneki-Tokunaga, Akira Yamasaki, Seiji Kageyama, Naoto Burioka, Hiroki Chikumi

Background: Rapid antigen tests are widely used to diagnose influenza. However, despite their simplicity and short turnover time, the sensitivity of these tests is relatively low, and molecular tests with greater sensitivity are being sought. In this study, we developed and clinically evaluated a protocol for the rapid multiplex testing of influenza A and B, using a rapid real-time PCR system, GeneSoC®, that is based on microfluidic thermal cycling technology.

Methods: The specificity of the developed assay was validated using cultured viral strains of influenza A/B, human metapneumovirus, and respiratory syncytial virus. Analytical sensitivity was evaluated using serially diluted RNA synthesized via in vitro transcription and nasopharyngeal swab samples collected from consecutive patients seeking medical attention for a combination of upper respiratory and general symptoms. Cross-validation of GeneSoC® based on comparisons with conventional real-time RT-PCR and rapid antigen tests was performed by parallel testing of influenza-positive clinical specimens.

Results: The GeneSoC® assay detected the target sequences of influenza A and B at minimum concentrations of 38 and 65 copies/µL in reaction, respectively. For the analysis of clinical specimens, the positive, negative, and overall agreement between GeneSoC® RT-PCR and a conventional real-time RT-PCR was in all cases 100%, whereas for the comparison between GeneSoC® RT-PCR and the rapid antigen test, the agreements for positive, negative, and overall findings were 100%, 90.9%, and 95.7%, respectively. The mean time for completing GeneSoC® RT-PCR was 16 min 29 s (95% confidence interval, 16 min 18 s to 16 min 39 s).

Conclusion: The microfluidic real-time PCR system, GeneSoC®, has an analytical performance comparable to that of conventional real-time RT-PCR with rapid turnover time, and represents a promising alternative to rapid antigen tests for diagnosing influenza A and B.

背景:快速抗原检测被广泛用于流感的诊断。然而,尽管这些检测方法简单,周转时间短,但灵敏度相对较低,人们正在寻找灵敏度更高的分子检测方法。在本研究中,我们开发并临床评估了一种快速多重检测甲型和乙型流感的方案,使用基于微流控热循环技术的快速实时PCR系统GeneSoC®。方法:采用流感A/B、人偏肺病毒和呼吸道合胞病毒培养的病毒株验证该方法的特异性。通过体外转录合成的连续稀释RNA和从因上呼吸道和一般症状合并就诊的连续患者收集的鼻咽拭子样本,评估分析灵敏度。通过对流感阳性临床标本进行平行检测,将GeneSoC®与传统实时RT-PCR和快速抗原检测相比较,进行交叉验证。结果:GeneSoC®检测分别在最低浓度为38拷贝/µL和65拷贝/µL时检测到甲型流感和乙型流感的目标序列。对于临床标本的分析,GeneSoC®RT-PCR与传统实时RT-PCR之间的阳性、阴性和总体一致性在所有情况下均为100%,而GeneSoC®RT-PCR与快速抗原检测之间的比较,阳性、阴性和总体结果的一致性分别为100%、90.9%和95.7%。完成GeneSoC®RT-PCR的平均时间为16 min 29 s(95%置信区间为16 min 18 s ~ 16 min 39 s)。结论:微流控实时PCR系统GeneSoC®具有与传统实时RT-PCR相当的分析性能,周转时间快,是诊断甲型和乙型流感的快速抗原检测的有希望的替代方法。
{"title":"Rapid Multiplex RT-PCR for Influenza A and B by Genesoc<sup>®</sup>, a Microfluidic PCR System.","authors":"Miyako Takata,&nbsp;Masaki Nakamoto,&nbsp;Tsuyoshi Kitaura,&nbsp;Kensaku Okada,&nbsp;Akeno Tsuneki-Tokunaga,&nbsp;Akira Yamasaki,&nbsp;Seiji Kageyama,&nbsp;Naoto Burioka,&nbsp;Hiroki Chikumi","doi":"10.33160/yam.2023.05.007","DOIUrl":"https://doi.org/10.33160/yam.2023.05.007","url":null,"abstract":"<p><strong>Background: </strong>Rapid antigen tests are widely used to diagnose influenza. However, despite their simplicity and short turnover time, the sensitivity of these tests is relatively low, and molecular tests with greater sensitivity are being sought. In this study, we developed and clinically evaluated a protocol for the rapid multiplex testing of influenza A and B, using a rapid real-time PCR system, GeneSoC<sup>®</sup>, that is based on microfluidic thermal cycling technology.</p><p><strong>Methods: </strong>The specificity of the developed assay was validated using cultured viral strains of influenza A/B, human metapneumovirus, and respiratory syncytial virus. Analytical sensitivity was evaluated using serially diluted RNA synthesized via <i>in vitro</i> transcription and nasopharyngeal swab samples collected from consecutive patients seeking medical attention for a combination of upper respiratory and general symptoms. Cross-validation of GeneSoC<sup>®</sup> based on comparisons with conventional real-time RT-PCR and rapid antigen tests was performed by parallel testing of influenza-positive clinical specimens.</p><p><strong>Results: </strong>The GeneSoC<sup>®</sup> assay detected the target sequences of influenza A and B at minimum concentrations of 38 and 65 copies/µL in reaction, respectively. For the analysis of clinical specimens, the positive, negative, and overall agreement between GeneSoC<sup>®</sup> RT-PCR and a conventional real-time RT-PCR was in all cases 100%, whereas for the comparison between GeneSoC<sup>®</sup> RT-PCR and the rapid antigen test, the agreements for positive, negative, and overall findings were 100%, 90.9%, and 95.7%, respectively. The mean time for completing GeneSoC<sup>®</sup> RT-PCR was 16 min 29 s (95% confidence interval, 16 min 18 s to 16 min 39 s).</p><p><strong>Conclusion: </strong>The microfluidic real-time PCR system, GeneSoC<sup>®</sup>, has an analytical performance comparable to that of conventional real-time RT-PCR with rapid turnover time, and represents a promising alternative to rapid antigen tests for diagnosing influenza A and B.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"223-231"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203650/pdf/yam-66-223.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi. 过敏性支气管肺真菌病不同病原菌的临床特点不同。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.016
Tomoya Harada, Genki Inui, Hiroki Ishikawa, Ryohei Kato, Yuriko Sueda, Yoshihiro Funaki, Miki Takata, Ryota Okazaki, Masato Morita, Shin Kitatani, Akira Yamasaki

Background: Allergic bronchopulmonary mycosis (ABPM) occurs with fungi, other than Aspergillus fumigatus. However, the clinical characteristics of ABPM caused by non-Aspergillus species are unspecified.

Methods: We retrospectively reviewed all patients with ABPM who visited to our hospital between April 2005 and December 2020. The causative fungi and clinical characteristics were analyzed. Patients were divided into the Aspergillus group and the non-Aspergillus group.

Results: Fourteen patients and five patients were included in the Aspergillus group and the non-Aspergillus group, respectively. Compared to the Aspergillus group, the non-Aspergillus group had a significantly low serum immunoglobulin E level and low forced vital capacity. In addition, the non-Aspergillus group had a lower rate of the requirement for oral corticosteroid treatment and a low frequency of recurrence.

Conclusion: Patients with non-Aspergillus ABPM had lower type 2 inflammation than did patients with allergic bronchopulmonary aspergillosis.

背景:变应性支气管肺真菌病(ABPM)发生于真菌,而不是烟曲霉。然而,非曲霉菌引起的ABPM的临床特征尚未明确。方法:回顾性分析2005年4月至2020年12月在我院就诊的所有ABPM患者。分析病原菌及临床特点。将患者分为曲霉组和非曲霉组。结果:曲霉组14例,非曲霉组5例。与曲霉组相比,非曲霉组血清免疫球蛋白E水平和肺活量显著降低。此外,非曲霉组口服皮质类固醇治疗的需求率较低,复发率较低。结论:与变应性支气管肺曲霉菌病患者相比,非曲霉菌ABPM患者的2型炎症发生率较低。
{"title":"The Clinical Characteristics of Allergic Bronchopulmonary Mycosis Differ Among Pathogenic Fungi.","authors":"Tomoya Harada,&nbsp;Genki Inui,&nbsp;Hiroki Ishikawa,&nbsp;Ryohei Kato,&nbsp;Yuriko Sueda,&nbsp;Yoshihiro Funaki,&nbsp;Miki Takata,&nbsp;Ryota Okazaki,&nbsp;Masato Morita,&nbsp;Shin Kitatani,&nbsp;Akira Yamasaki","doi":"10.33160/yam.2023.05.016","DOIUrl":"https://doi.org/10.33160/yam.2023.05.016","url":null,"abstract":"<p><strong>Background: </strong>Allergic bronchopulmonary mycosis (ABPM) occurs with fungi, other than <i>Aspergillus fumigatus</i>. However, the clinical characteristics of ABPM caused by non-<i>Aspergillus</i> species are unspecified.</p><p><strong>Methods: </strong>We retrospectively reviewed all patients with ABPM who visited to our hospital between April 2005 and December 2020. The causative fungi and clinical characteristics were analyzed. Patients were divided into the <i>Aspergillus</i> group and the non-<i>Aspergillus</i> group.</p><p><strong>Results: </strong>Fourteen patients and five patients were included in the <i>Aspergillus</i> group and the non-<i>Aspergillus</i> group, respectively. Compared to the <i>Aspergillus</i> group, the non-<i>Aspergillus</i> group had a significantly low serum immunoglobulin E level and low forced vital capacity. In addition, the non-<i>Aspergillus</i> group had a lower rate of the requirement for oral corticosteroid treatment and a low frequency of recurrence.</p><p><strong>Conclusion: </strong>Patients with non-<i>Aspergillus</i> ABPM had lower type 2 inflammation than did patients with allergic bronchopulmonary aspergillosis.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"257-262"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203632/pdf/yam-66-257.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Related to Turnover and Intention to Leave the Care Working Profession in Japan: A Review. 日本护理人员离职及离职意向的相关因素分析。
IF 1 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-05-01 DOI: 10.33160/yam.2023.05.001
Shinya Takeda

Globally, the elderly population is growing rapidly. The number of elderly people requiring nursing care is expected to increase along with the elderly population. However, the high turnover rate of care workers has caused a labor shortage, which in turn has encouraged further turnover, creating a vicious cycle. Preventing turnover is an important issue not only for the physical and mental health of care workers but also for the quality of nursing care. In particular, Japan has emerged as the world's first super-aged society, experiencing an increase in the number of elderly people requiring nursing care and a shortage of care workers. This review summarizes the research on factors influencing care worker turnover and intent to leave the profession in Japan. Additionally, workplace interpersonal problems have been shown to be consistently associated with care worker turnover or intention to leave in previous studies that were reviewed.

在全球范围内,老年人口正在迅速增长。随着老年人口的增加,需要护理的老年人数量预计会增加。然而,护工的高流动率造成了劳动力短缺,反过来又鼓励了进一步的流动,形成了一个恶性循环。预防离职不仅关系到护理人员的身心健康,而且关系到护理质量。特别是,日本已经成为世界上第一个超级老龄化社会,需要护理的老年人数量增加,护理人员短缺。本文综述了日本护理工作者离职和离职意向影响因素的研究。此外,在之前的研究中,工作场所的人际关系问题已被证明与护理人员的离职或离职意图始终相关。
{"title":"Factors Related to Turnover and Intention to Leave the Care Working Profession in Japan: A Review.","authors":"Shinya Takeda","doi":"10.33160/yam.2023.05.001","DOIUrl":"https://doi.org/10.33160/yam.2023.05.001","url":null,"abstract":"<p><p>Globally, the elderly population is growing rapidly. The number of elderly people requiring nursing care is expected to increase along with the elderly population. However, the high turnover rate of care workers has caused a labor shortage, which in turn has encouraged further turnover, creating a vicious cycle. Preventing turnover is an important issue not only for the physical and mental health of care workers but also for the quality of nursing care. In particular, Japan has emerged as the world's first super-aged society, experiencing an increase in the number of elderly people requiring nursing care and a shortage of care workers. This review summarizes the research on factors influencing care worker turnover and intent to leave the profession in Japan. Additionally, workplace interpersonal problems have been shown to be consistently associated with care worker turnover or intention to leave in previous studies that were reviewed.</p>","PeriodicalId":23795,"journal":{"name":"Yonago acta medica","volume":"66 2","pages":"196-201"},"PeriodicalIF":1.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203648/pdf/yam-66-196.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9528297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Yonago acta medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1